{"transactions":[{"id":1603901,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-04T19:18:03.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter.  \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter.  \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-24-006416","document":"form4-03052024_120358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1137918/000141588924006416/form4-03052024_120358.xml","form_type":"4"}},{"id":1603900,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2024-03-04T19:18:03.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":60000,"derivative":{"exercise_price":1.92,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-006416","document":"form4-03052024_120358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137918/000141588924006416/form4-03052024_120358.xml","form_type":"4"}},{"id":1603899,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2024-03-04T19:18:03.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":76813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date.  \"Grant Date\" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance."}],"balance_after":76813,"derivative":{"exercise_price":1.92,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":76813},"source":{"system":"sec-edgar","filing":"0001415889-24-006416","document":"form4-03052024_120358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137918/000141588924006416/form4-03052024_120358.xml","form_type":"4"}},{"id":1980220,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-03-02T16:10:30.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":102350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 1, 2023."}],"balance_after":102350,"derivative":{"exercise_price":10.93,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":102350},"source":{"system":"sec-edgar","filing":"0001209191-23-014615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137918/000120919123014615/doc4.xml","form_type":"4"}},{"id":2305250,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-04-05T20:18:13.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":67300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2022."}],"balance_after":67300,"derivative":{"exercise_price":17.24,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":67300},"source":{"system":"sec-edgar","filing":"0001209191-22-023351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137918/000120919122023351/doc4.xml","form_type":"4"}},{"id":2535717,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-10-25T19:27:15.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean October 21, 2021."}],"balance_after":185000,"derivative":{"exercise_price":26.85,"expiration_date":"2031-10-21","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0000899243-21-041483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137918/000089924321041483/doc4.xml","form_type":"4"}},{"id":3001153,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-23T17:34:04.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-20-117800","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117800/a4.xml","form_type":"4"}},{"id":3001152,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-10-23T17:34:04.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-117800","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117800/a4.xml","form_type":"4"}},{"id":3268900,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":93582,"kind":"person","name":"ITRI LORETTTA M","position":1,"cik":"0001137918","reported_name":"ITRI LORETTTA M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-18T19:11:09.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period."}],"balance_after":130000,"derivative":{"exercise_price":18.76,"expiration_date":"2027-02-13","underlying":"Common Stock, par value $0.01 per share","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001104659-20-022514","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920022514/a4.xml","form_type":"4"}}]}